Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma Market Cap : 1.731M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 1.731M |
| November 17, 2026 | 1.849M |
| November 16, 2026 | 1.858M |
| November 13, 2026 | 1.908M |
| November 12, 2026 | 1.888M |
| November 11, 2026 | 1.809M |
| November 10, 2026 | 1.711M |
| November 09, 2026 | 5.827M |
| November 06, 2026 | 5.860M |
| November 05, 2026 | 5.430M |
| November 04, 2026 | 5.926M |
| November 03, 2026 | 5.662M |
| November 02, 2026 | 5.695M |
| October 30, 2026 | 6.092M |
| October 29, 2026 | 6.986M |
| October 28, 2026 | 6.986M |
| October 27, 2026 | 8.045M |
| October 26, 2026 | 7.582M |
| October 23, 2026 | 9.270M |
| October 22, 2026 | 9.072M |
| October 21, 2026 | 10.44M |
| October 20, 2026 | 10.63M |
| October 19, 2026 | 1.050M |
| October 16, 2026 | 1.132M |
| October 15, 2026 | 1.131M |
| Date | Value |
|---|---|
| October 14, 2026 | 1.211M |
| October 13, 2026 | 1.366M |
| October 12, 2026 | 1.457M |
| October 09, 2026 | 1.608M |
| October 08, 2026 | 1.559M |
| October 07, 2026 | 1.651M |
| October 06, 2026 | 1.627M |
| October 05, 2026 | 1.655M |
| October 02, 2026 | 1.680M |
| October 01, 2026 | 1.659M |
| September 30, 2026 | 1.636M |
| September 29, 2026 | 1.696M |
| September 28, 2026 | 1.766M |
| September 25, 2026 | 2.087M |
| September 24, 2026 | 1.992M |
| September 23, 2026 | 2.079M |
| September 22, 2026 | 2.155M |
| September 21, 2026 | 0.5506M |
| September 18, 2026 | 0.5334M |
| September 17, 2026 | 0.5509M |
| September 16, 2026 | 0.5552M |
| September 15, 2026 | 0.717M |
| September 14, 2026 | 0.7432M |
| September 11, 2026 | 0.8053M |
| September 10, 2026 | 0.8244M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Immutep Ltd. | 23.95M |
| CSL Ltd. | 63.02B |
| Ceryvyn Therapeutics Ltd. | 4.788M |
| Mesoblast Ltd. | 1.509B |
| Actinogen Medical Ltd. | 1.090B |
Market Cap Related Metrics
| Price to Book Value | 0.2448 |
| Price | 1.76 |
| Earnings Yield | -1.60K% |